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Abstract  20 
The activation of nicotinic cholinergic receptors (nAChR) inhibits the reproductive axis; however, it 21 
is not clear whether nicotine may directly modulate the release of hypothalamic gonadotropin-22 
releasing hormone (GnRH). Experiments carried out in GT1-1 immortalized GnRH neurons reveal 23 
the presence of a single class of high affinity 42 and 7 nAchR subtypes. The exposure of GT1-1 24 
cells to nicotine does not modify the basal accumulation of GnRH. However, nicotine was found to 25 
modify GnRH pulsatility in perifusion experiments and inhibits, the release of GnRH induced by 26 
prostaglandin E1 or by K
+-induced cell depolarization; these effects were reversed by D-27 
tubocurarine and -bungarotoxin. In conclusion, the results reported here indicate that: functional 28 
nAChRs are present on GT1-1 cells, the activation of the -bungarotoxin-sensitive subclass (7) 29 
produces an inhibitory effect on the release of GnRH and that the direct action of nicotine on 30 
GnRH neurons may be involved in reducing fertility of smokers. 31 
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1. Introduction  41 
Cigarette smoking may have adverse effects on fertility. It has been shown that the activation of 42 
nicotinic acetylcholine receptors (nAChR) inhibits the activity of the hypothalamus-pituitary-43 
gonadal axis at several levels. For example, it has been reported that nicotine inhibits 44 
steroidogenesis in Leydig cells as well as sperm motility and oocyte maturation (Condorelli et al., 45 
2013; Gocze et al., 1996; Yamamoto et al., 1998; Zenzes, 2000).  46 
In vivo and in vitro activation of acetylcholine receptors leads to either stimulatory or inhibitory 47 
effects on GnRH secretion (Kalra and Kalra, 1983; Kawai et al., 2013; Koren et al., 1992; Richardson 48 
et al., 1982), leaving the nature of action of cholinergic input on GnRH neurons unresolved. 49 
It has also been shown that the specific activation of nAChR affects the hypothalamic-pituitary-50 
gonadal axis.  In particular, nicotine induces a decrease of the release of luteinizing hormone 51 
possibly acting at the pituitary level (Blake et al., 1972; Fiorindo and Martini, 1975; Kanematsu and 52 
Sawyer, 1973; Motta et al., 1973; Zemkova et al., 2013). However, it is not clear whether nicotine 53 
can modulate the release of the hypothalamic gonadotropin releasing hormone (GnRH).   54 
It has been shown that nicotine administration may inhibit the activity of the gonadotropin-55 
releasing hormone (GnRH) pulse generator in ovariectomized rats (Sano et al., 1999). However, it 56 
has been postulated that nicotine action could be mediated by a potentiation of the inhibitory 57 
tone exerted by opioid peptides on GnRH/gonadotropin release (Hodson et al., 1997); conversely, 58 
experimental evidence might exclude this hypothesis (Sano et al., 1999). Kimura and coworkers 59 
(Kimura et al., 2004) have further reported that, in the cultured embryonic olfactory placode, 60 
nicotine inhibits GnRH secretion through a release of GABA and the consequent activation of 61 
GABA-A receptor system.  62 
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It cannot be excluded that the nicotinic cholinergic system might also act directly on GnRH 63 
secreting neurons, as acetylcholine induces a rapid, but transient, stimulation of GnRH release in 64 
perifused hypothalamic and immortalized GnRH neurons (Krsmanovic et al., 1998).  65 
Considering that the affinity of nicotine to nAChR ranges from pM to nM values and that after 66 
inhalation of a single puff of cigarette smoke, the nicotine concentration in human arterial plasma 67 
rise to a peak of about 50-100 ng/ml (0.3-0.  in about 20 sec (Crandall et al., 1989), an effect 68 
of nicotine on GnRH release should be carefully evaluated. 69 
 70 
Neuronal nAChRs are a heterogeneous family of acetylcholine (Ach)-gated channels with a 71 
pentameric structure resembling that of muscle AchRs. Mammalian nAChRs can be subdivided 72 
into two main classes: homomeric or heteromeric α-bungarotoxin (αBgtx)–sensitive receptors 73 
consisting of α7, α9, α9-α10, α72 subunits, and αBgtx-insensitive heteromeric receptors 74 
consisting of α2– α6 and 2– 4 subunits (reviewed in (Millar and Gotti, 2009; Zoli et al., 2015)). 75 
The two classes of receptors are characterized by distinct pharmacological profiles wherein: the 76 
αBgtx-insensitive heteromeric receptors are bound by nicotine agonists with a very high affinity 77 
but not by the antagonist αBgtx, whereas the αBgtx–sensitive receptors are bound by agonists 78 
with lower affinity but with high αBgtx affinity (Dutton and Craik, 2001). All of the nAChR subtypes, 79 
but in particular the α7 subtype, show pronounced permeability for Ca2+ relative to Na+; and many 80 
of the biological functions identified for nAChRs have been associated with receptor-mediated 81 
changes in intracellular Ca2+  concentration which modulate the release of several 82 
neurotransmitters. Data from distribution of nAChR 83 
present in the hypothalamic region (see (Millar and Gotti, 2009) for a review) while α9 is 84 
expressed predominantly in hair cells of the cochlea. 85 
In the present work we evaluated the presence of nicotinic receptors and the nature of a direct 86 
effect of nicotine on GnRH secretion in a neuronal isolated system using cell lines of immortalized 87 
hypothalamic GnRH neurons, an in vitro model widely used to study the mechanisms that control 88 
GnRH release in controlled conditions (Glidewell-Kenney et al., 2013; Gore and Roberts, 1997; 89 
Krsmanovic et al., 1998; Maggi et al., 1995; Maggi et al., 1995; Maggi et al., 2000; Mellon et al., 90 
1990; Pal et al., 2007; Pimpinelli et al., 1999).   91 
  4 
2. Materials and Methods  92 
2.1 Chemicals 93 
Nicotine tartrate and prostaglandin E1 (PGE1) were from Sigma Chemicals (St.Louis, MO), 94 
nonradioactive epibatidine  α-bungarotoxin (αBgtx) and D-tubocurarine (D-Tub) were from 95 
Tocris  Bioscience (Bristol, UK). When not specified, other reagents were from Sigma Chemicals 96 
(St.Louis, MO). 97 
 98 
2.2 Cell cultures 99 
GT1-1 cells, generously provided by Dr. R.I. Weiner (San Francisco, CA) through Dr. B. Marchetti 100 
(Catania, Italy) and human embryonic kidney cells (HEK )293 were routinely grown in monolayer at 101 
37 °C in a humidified CO2 incubator in Dulbecco's Minimum Essential Medium (DMEM) containing 102 
1 mM sodium pyruvate, 100 mg/ml streptomycin, 100 U/ml penicillin and 10 mg/l of phenol red 103 
(Biochrom KG, Berlin, Germany) and supplemented with 10% fetal calf serum (FCS, Gibco, Grand 104 
Island, NY). The medium was replaced at 2-day intervals. Subconfluent cells were routinely 105 
harvested by trypsinization and seeded in 57 cm2 dishes (1 x 106 cells) for propagation. For all the 106 
experiments, GT1-1 cells within 6 passages were used.  107 
Receptor binding  108 
Subconfluent GT1-1 or HEK293 cells were detached from the subconfluent culture using 109 
phosphate buffer saline (PBS) containing 1 mM PMFS, washed twice by centrifugation, 110 
resuspended in 50 mM TrisHCl pH 7.4 containing 50 mM NaCl, 2 mM EDTA, 2 mM EGTA, 5 mg/ml 111 
mixture of the protease inhibitors leupeptin, bestatin, pepstatin A, aprotinin and 1 mM PMFS and 112 
homogenized to obtain a crude membrane preparation.  113 
All the incubations were performed in a buffer containing 50 mM Tris-HCl pH 7, 150 mM NaCl, 5 114 
mM KCl, 1 mM MgCl2, 2.5 mM CaCl2, and 2 mg/ml BSA. 115 
The binding of 3H-Epibatidine (Epi, epibatidine specific activity: 66 Ci/mmol was purchased from 116 
Perkin Elmer (Waltham, MA, USA),  and 125I-α-bungarotoxin (αBgtx, specific activity: 122.8 117 
Ci/mmol was purchased from Perkin Elmer (Waltham, MA, USA ) were performed by a 118 
homogeneous saturation binding assay according to a mixed protocol combining both saturation 119 
of labeled ligand (the first 7-8 concentrations of respectively 0.005-5 nM and 0.01-20 nM) and 120 
displacement curves (the last 3-4 concentrations of 50-1000 nM for both ligands) with unlabeled 121 
ligand (Rovati et al., 1989). By effectively combining both saturation and competition protocols in 122 
a single curve, high ligand concentrations can be reached without using excessive amounts of 123 
labeled ligand (the competition part of the curve), while retaining adequate radioactivity in the 124 
lower concentration range (the saturation part of the curve). 125 
Non-specific binding (averaging 5-10% of total binding for Epi and 25-30% of total binding for 126 
αBgtx was determined in the presence of 2 µM unlabeled ligands. 127 
Saturation experiments were performed by incubating aliquots of GT1-1 crude membrane 128 
preparations with ligands overnight at 20°C. At the end of the incubation, the samples were 129 
filtered through a 24-channel Brandel cell harvester on GFC filters presoaked in buffer +1% BSA, 130 
five  times with ice-cold buffer, and the bound radioactivity then determined by means of liquid 131 
scintillation spectrometer (Packard 1600 CA, Packard, Milano, Italy) with 60% of efficiency. 132 
 133 
2.3 RT-PCR assay 134 
For expression studies, cells were washed with cold PBS, and collected with TRIzol (Invitrogen) and 135 
total RNA was extracted following the manufacturer's protocol. Mouse hypothalami, collected 136 
from adult animals, were homogenized in TRIzol and RNA extracted following the manufacturer's 137 
protocol. One microgram of total RNA was subjected to cDNA synthesis with Superscript II reverse 138 
transcriptase (Invitrogen), using random hexamers according to standard procedures. PCRs were 139 
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performed using Taq PCR Core Kit (Qiagen) and the following oligonucleotides; 4) forward 5’-140 
CAATGTACACCACCGCTCAC-3’ and reverse 5’-TGGTCTGACACTGGAAGCTG-3’, 7) forward 5’-141 
GCACCTCATGCATGGTACAC-3’ and reverse 5’-ATCCAGAGTGGGCAATGAC-3’, 9) forward 5’-142 
CCTTGCGTCCTCATATCGTT-3’ and reverse 5’-CCCTGGAAGTTTGCCATAAA-3’, 2) forward 5’-143 
TGGCTGTGTTCAGGGGTTTT-3’ and reverse 5’-CCTCAATCTTGCATGCGCTC-3’. 144 
The mouse Gapdh gene was analyzed as housekeeping gene with the following PCR primers: 145 
forward 5′-GGCCCCTCTGGAAAGCTGTGG-3′ and reverse 5′-TCTTGCTCAGTGTCCTTGCTGGG-3′. 146 
Amplification products were separated by 1% agarose gel electrophoresis and detected by 147 
ethidium bromide fluorescence on a UV transilluminator (Bio-Rad). 148 
 149 
2.4 GnRH release form perifused GT1-1 cells  150 
Perifusion experiments were performed as already described (Magni et al., 1999). In brief, GT1–1 151 
cells were grown on Cytodex-3 beads (Pharmacia Biotech, Uppsala, Sweden). After 3–4 days, cells 152 
were loaded into temperature-controlled glass syringes, the final cell-matrix volume was adjusted 153 
to 0.15 ml. Chambers were perifused at a flow rate of 10 ml/h with Locke’s, gassed with 95% O2–154 
5% CO2 at 37 C. After a 2-h equilibration period, samples were collected every 90 sec and stored 155 
at -20 C until radioimmunoassayed for GnRH. Cells were perifused for the first hour with Locke’s 156 
medium, and then with medium containing nicotine (500 M) for 30 min. GnRH pulses were 157 
identified and their parameters were determined by a computer algorithm cluster analysis 158 
(Veldhuis and Johnson, 1986). The occurrence and the duration of pulses are shown above each 159 
plot. 160 
 161 
2.5 GnRH accumulation in GT1-1 cell culture medium 162 
GT1-1 neurons were plated in 24-well plates (0.5 x 106 cells/cm2) and used after five days of 163 
culture. Art the day of the experiment, cells were washed with 1 ml of DMEM (prewarmed at 37° 164 
C) and, when not otherwise specified, incubated for 30 min in DMEM containing the substances to 165 
be tested. At the end of the incubation period, the medium was collected, centrifuged for 5 min at 166 
12.000 rpm and the supernatant stored at -70 C until the GnRH RIA (Maggi et al., 1995). The cells 167 
remaining in the culture wells were collected in 0.2 M NaOH, and assayed for protein content 168 
using a microassay with human serum albumin as a standard. No variations of total protein/well 169 
were detected in all the experimental groups (data not shown). 170 
For the experiments performed in the presence of depolarizing extracellular concentrations of K+ 171 
ions, DMEM was substituted by Locke’s medium containing 5.6 mM or 56 mM K+ (Pimpinelli et al., 172 
2003). 173 
 174 
2.6 GnRH radioimmunoassay 175 
The concentration of GnRH in the media and in the fractions collected during the perifusion as well 176 
as static experiments was determined by RIA using a commercial antibody (Cod. L-8391, Sigma 177 
Chemicals, St Louis, MO) and iodinated GnRH (Amersham, Milano, Italy). The GnRH standard was 178 
from NovaBiochem (Laufelfingen, Switzerland) (Maggi et al., 1995; Pimpinelli et al., 1999). All 179 
samples were run in duplicate; the detection limit was 3.9 pg/ml. The inter- and intra-assay 180 
coefficients of variation were 9.4% and 6.6%, respectively. Each experiment was repeated at least 181 
three times. 182 
 183 
2.7 cAMP assay 184 
For cAMP experiments, GT1-1 cells were plated in 24-wells plates (0.5 x 106 cells/cm2) and used 185 
after three days of culture (Pimpinelli et al., 1999). All the samples were assayed for protein 186 
content using a microassay with human serum albumin as a standard. Intracellular cAMP 187 
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accumulation was measured over a 15-minutes incubation period with 1 µM of prostaglandin E1 188 
(PGE1) (Sigma, St. Louis, MO), as activators of adenylyl cyclase, after a 10 minutes preincubation 189 
with 0.5 mM 3-isobutyl-1-methyl-xanthine (Sigma Chemicals, St. Louis, MO). A commercial 190 
available binding-protein assay kit (Amersham, Milano, Italy) was used to evaluate cAMP levels in 191 
ethanol extracted cells according to manufacturers' instructions.  192 
 193 
2.8 Statistical analysis  194 
Receptor binding experiments were optimized with the program DESIGN (Rovati et al., 1990) and 195 
the results further analyzed by the program LIGAND (Munson and Rodbard, 1980). The statistic 196 
software PRISM was used to analyze the dose-response curves, by a four parameter non-linear 197 
regression, and the other results, by ANOVA and adequate post-hoc tests (Dunnett's or 198 
Bonferroni's test). 199 
 200 
  201 
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3. Results  202 
3.1 Detection of nAChR in GT1-1 cells 203 
A series of experiments were performed to investigate, using different approaches, the presence 204 
of nAChRs in GT1-1 cells. 205 
Receptor binding assays on GT1-1 membrane preparations were carried out using labeled Epi, an 206 
azabicycloheptane alkaloid exerting potent nicotinic agonist action for heteromeric receptors, and 207 
αBgtx that binds with high affinity the homomeric nAChR. Epi binds to several heteromeric nAChR 208 
subtypes with a Kd in the pM range whereas its binding to the α7 homomeric subtype is in the nM 209 
range and competitive with that of αBgtx. 210 
We then analyzed the saturation binding of Epi on separate preparations of GT1-1 cell 211 
homogenates in the presence of 2 M unlabeled αBgtx to avoid possible binding to homomeric 212 
receptors. In these conditions, a specific and saturable Epi binding with a Kd of 13 pM and a Bmax 213 
(mean + SE) of 6.6 + 3.5 fmol/mg of protein was observed (Fig. 1A).  214 
Saturation binding experiments performed with αBgtx, also revealed a single high affinity site with 215 
a Kd of 2.8 nM and a Bmax (mean + SE) of 16.6 + 3.5 fmol/mg of protein (Fig. 1B).  216 
As a control the binding of both Epi and αBgtx was tested on membrane preparations from 217 
HEK293 cells, that does not express nAchR (Chavez-Noriega et al., 2000; Craig et al., 2004). The 218 
results, shown in Fig. 1 A and B clearly indicate a negligible, mainly nonspecific, binding of the two 219 
ligands impossible to resolve for parameter estimation by LIGAND program. 220 
These results indicate the presence of independent high affinity binding sites for both Epi and 221 
αBgtx on GT1-1 cell membranes, and suggest the presence of at least two distinct populations of 222 
nAChR subtypes. 223 
Based on data indicating the presence of 42 and 7 nAChR subunits in mouse hypothalamus 224 
and transcriptomic analysis (Affymetrics mouse 2.0, data not shown) of GT1 cell extracts revealing 225 
the presence of signals for α7, α4 and 2 nicotine receptor subunits, we analyzed the presence of 226 
specific transcripts for these nicotine receptor subunits by RT-PCR. The transcript analysis, carried 227 
out on total RNA extracted from GT1-1 cells, showed the presence  of transcripts for α7, α4 and 2 228 
subunits of nAChR (Fig. 1C). The transcript for α9 subunit, analyzed as a control, was not 229 
detectable in GT1-1 cell extract (data not shown). 230 
 231 
3.2 Effects of the activation of nAChR by nicotine on basal GnRH release 232 
The effect of receptor activation on the accumulation of GnRH released from GT1-1 cells was 233 
evaluated. Graded concentrations of nicotine (1-500 µM) and/or nicotine antagonists (αBgtx and 234 
D-Tub) were added to GT1-1 cells maintained in basal culture conditions and GnRH accumulation 235 
in the culture medium over a 30 min interval was evaluated by radioimmunoassay. Nicotine or its 236 
antagonists did not significantly affect basal GnRH release from GT1-1 cells (Fig. 2A). Similarly, 237 
exposure to the nAChR antagonists αBgtx and D-Tub did not significantly affect GnRH release.  238 
 239 
3.3 Effects of the activation of nAChR by nicotine on pulsatile GnRH release 240 
To explore whether the possible action of nicotine receptor activation on GnRH release could have 241 
modified the dynamic, rather than the total amount, of GnRH release, a series of perifusion 242 
experiments were performed. 243 
GT1-1 cells were cultured as described in Materials and Method and perifused for 30 minutes with 244 
a 500 M solution of nicotine. This concentration was selected considering the results obtained in 245 
the experiment on GnRH accumulation and the consolidated notion that nAch requires high 246 
concentrations of agonist to couple binding to channel opening and, conversely, low 247 
concentrations of agonist may induce a rapid desensitization of receptors followed by an increase 248 
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in their number (Quick and Lester, 2002); this phenomenon may produce biphasic responses that 249 
complicate biological interpretation. The medium was collected at different time intervals during 250 
the infusion and subjected to radioimmunoassay.  251 
As expected, we found that the basal release of GnRH by GT1–1 cells is intrinsically pulsatile (Fig. 252 
2B) with a mean pulse frequency of 2.58 ± 0.54 pulses/hour (mean ± SD), as detected by cluster 253 
analysis on 6 independent experiments (Magni et al., 1999). After a 30-60 min of preconditioning 254 
in basal conditions, nicotine (at 500 M concentration) was added to the perifusion medium. The 255 
cells were exposed to nicotine for 30 min followed by a 30-40 min of washing The results show a 256 
change of the secretory peaks characterized by a significantly increased pulse frequency (5.13 ± 257 
1.03 pulse/hour; p<0.05), associated with a reduced pulse duration during nicotine exposure and 258 
for few minutes after the withdrawal of treatment withdrawal, followed by a rapid return to a 259 
basal frequency (3.25 ± 0.35 pulse/hour)(Fig. 2B). The baseline secretory activity of GT1–1 cells, as 260 
well as their response to nicotine were different among perifusion experiments due to intrinsic 261 
features of this system; however, the effect of nicotine was qualitatively similar when measured 262 
over independent experiments. However, in agreement with static experiments, the amount of 263 
GnRH released, calculated as the area under the curve, was not significantly different before and 264 
during nicotine exposure (data not shown). 265 
 266 
3.4 Effects of the activation of nAChR by nicotine on PGE1 stimulated GnRH release and cAMP 267 
accumulation 268 
Since the release of hypothalamic GnRH is regulated by several stimulatory inputs impinging on 269 
GnRH neurons (Hrabovszky and Liposits, 2013), we explored the possibility that the activation of 270 
nAChRs could exert an inhibitory effect on stimulated GnRH release. 271 
The release of GnRH was induced by exposure of GT1-1 cells to PGE1 as a GnRH secretagogue 272 
(Maggi et al., 1995; Pimpinelli et al., 1999) and treated with nicotine and the two nAChR 273 
antagonists  andαBgtx. 274 
Under these conditions, nicotine shows a significant and dose-dependent inhibition (IC50 214.0 ± 275 
26.6 µM) of GnRH accumulation induced by exposure of the cells to PGE1 (1 mM) (Fig. 3A). The 276 
inhibitory effect of nicotine is completely reversed by the presence of either of the nicotinic 277 
general nAChR antagonist D-Tub or antagonist of homomeric nAChRαBgtx, which, when given 278 
alone, do not significantly affect GnRH release in either basal or stimulated conditions (Fig. 3B and 279 
3C).  280 
Since in GT1-1 cells the secretagogue effect of PGE1 is mediated by intracellular accumulation of 281 
cAMP (Pimpinelli et al., 1999), we analyzed whether the effect of nicotine was mediated by 282 
modifications of the formation of this intracellular second messenger. The results (Figure 4) 283 
indicate that nicotine exposure does not affect the PGE1-induced of cAMP accumulation in GT1-1 284 
cells suggesting that a different intracellular pathway is involved. 285 
 286 
3.5 Effects of nicotine on high K+-induced GnRH release 287 
The effect of nicotine under GnRH stimulation by direct GT1-1 cell depolarization was 288 
subsequently investigated. During direct cell depolarization, induced by the exposure to high 289 
extracellular K+ concentration (56 mM) (Pimpinelli et al., 2003), nicotine still inhibits the release of 290 
GnRH  in a dose-dependent manner (IC50 121.7 ± 18.8 µM) (Fig. 5A); an effect that is reversed by 291 
the presence of either of the nicotine antagonists (Fig. 5B and 5C). 292 
 293 
  294 
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4. Discussion 295 
At least two classes of functional nAChR receptors are expressed in GT1-1 immortalized GnRH 296 
neurons. One class of such receptors is bound by Epi, a potent cholinergic agonist (Houghtling et 297 
al., 1995), with high affinity (pM range) and specificity. Epi is known to interact with high affinity 298 
with many heteromeric nAch receptors, and in particular with α4β2 (Gotti et al., 1997), the most 299 
represented form in mouse brain and hypothalamus (Flores et al., 1992; Millar and Gotti, 2009). 300 
However, it may also bind homomeric α7 nAch receptors, although with an affinity that is four 301 
orders of magnitude lower (Sullivan et al., 1994). 302 
Labeled αBgtx was also found to bind, with nM affinity, to a single class of sites on GT1-1 cell 303 
membranes. αBgtx selectively interacts with muscle nicotinic receptors (α1) and homomeric α7, 304 
expressed in different neural tissues, suggesting the presence of these receptors (McGehee and 305 
Role, 1995).  306 
The presence of nAChR  in GT1-1 cells was then confirmed  by RT-PCR experiments that revealed 307 
the presence of transcripts specific for 7 , 4 and 2 nAChR subunits.  308 
Considering the limitations of the in vitro cell model, these findings are in agreement with the 309 
reported main distribution of α7 and α4β2 nAChR in several hypothalamic structures  and in the 310 
median eminence (Clarke et al., 1985; Dominguez del Toro et al., 1994; Flores et al., 1992; Michels 311 
et al., 1986; Millar and Gotti, 2009), the brain region where the axons of GnRH-secreting neurons 312 
make contact with the hypothalamo-pituitary portal vessels. 313 
An anatomical relationship of cholinergic neuronal pathways and gonadotropin-releasing hormone 314 
neurons of the preoptic area has been indicated by the detection of cholinergic axons in 315 
apposition to gonadotropin-releasing hormone immunoreactive cell bodies and dendrites, 316 
providing direct neuromorphological evidence for the involvement of the cholinergic system in the 317 
regulation of gonadotropin-releasing hormone neurons (Turi et al., 2008). Similarly, we have 318 
previously demonstrated the presence of delta opiod receptors both on GT1-1 cells and in  319 
hypothalamic GnRH terminals (Maggi et al., 1995; Pimpinelli et al., 2006). 320 
The data reported here indicate that the activation of nAChRs present in GT1-1 cells by nicotine 321 
does not modify the constitutive basal GnRH release, although increased pulse frequency and 322 
decreased pulse duration of GnRH secretion was observed on exposure to the alkaloid. 323 
Using hypothalamic primary cell cultures and GT1-7 clone, Krsmanovic and coworkers (Krsmanovic 324 
et al., 1998) found a dual effect of Ach on GnRH neurons; while activation of M2 muscarinic 325 
receptors reduced basal GnRH release, the activation of M1 receptors resulted in a rapid and 326 
transient increase in GnRH neurosecretion. In addition, these authors reported that the treatment 327 
of GT1-7 neurons with nicotine (at 10 M concentration) caused a transient increase in GnRH 328 
pulsatility, even if no further characterization of the nicotine receptor involved or its specific 329 
activation were provided.  330 
On the other hand, the decrease of the pulse frequency reported here agrees with the observation 331 
that 'in vivo' nicotine may inhibit the activity of the GnRH pulse generator (Sano et al., 1999) by 332 
suppressing the neuronal multiunit activity (MUA) at the level of the median eminence. However, 333 
this study was carried out in ovariectomized animals, where the release of GnRH is highly 334 
stimulated, due to the lack of gonadal steroid-mediated negative feedback and the activation of 335 
neurostimulatory inputs. In fact, neurons in culture lack multiple neuronal afferents that impinge 336 
on hypothalamic GnRH neurons (Gore and Roberts, 1997; Pimpinelli et al., 1999). Accordingly, a 337 
potent dose-dependent inhibitory effect of nicotine was observed during the stimulation of GnRH 338 
release by PGE1  or to high extracellular K
+ concentration, an experimental condition more similar 339 
to that of native hypothalamic GnRH neurons (Pimpinelli et al., 1999; Pimpinelli et al., 2003).  340 
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Both these two conditions are powerful stimuli to increase cytosolic Ca2+ levels (Krsmanovic et al., 341 
1996; Martinez de la Escalera et al., 1995; Stojilkovic et al., 1994) that activates the release 342 
machinery of GnRH, even though they act with a different mechanism. In fact, while exposure to 343 
high K+ induces a direct depolarization of the cell (Mellon et al., 1991; Pimpinelli et al., 2003), PGE1 344 
acts through the formation of cAMP (Pimpinelli et al., 1999). We have similarly reported that 345 
opioid peptides were unable to modify the basal secretion of GnRH from the GT1-1 cells but they 346 
exerted an inhibitory effect under stimulation of GnRH release with prostaglandins (PGE1 and 347 
PGE2) (Maggi et al., 1995). 348 
This observation, indicating a significant inhibitory effect of nicotine on GnRH release, further 349 
affirms that GT1 cells resemble hypothalamic GnRH-secreting neurons only when they are 350 
properly stimulated (Gore and Roberts, 1997).  351 
The inhibitory effect of nicotine, both on cells stimulated with K+ or with PGE1, was efficiently 352 
blocked by D-Tub confirming the interaction of nicotine with nAChR. Significantly, αBgtx also 353 
completely blocks the effect of nicotine, indicating the involvement of αBgtx-sensitive nAChR 354 
present in GT1-1 neurons (α7) in the control of secretion of GnRH.  355 
Moreover, our investigation on the possible mechanism underlying these effects demonstrates 356 
that the inhibition of PGE1 -induced secretion of GnRH by nicotine is not mediated by a change in 357 
cAMP accumulation, suggesting a possible action downstream to the activation of this intracellular 358 
pathway.   359 
It has been described that the protein kinase A, protein kinase G and protein kinase C pathways 360 
are all functionally coupled to regulation of GnRH secretion by GT1 cells; in particular, the pulsatile 361 
secretion of GnRH is coupled to the entry of extracellular Ca2+ via L-type Ca2+ channels (Martinez 362 
de la Escalera et al., 1995; Zheng et al., 1997). Therefore cell depolarization triggers the Ca2+ entry 363 
response with consequent exocytosis of GnRH. The importance of cytoplasmic concentration of 364 
Ca2+ in GnRH release has been established both in native GnRH (Drouva et al., 1981; Ojeda et al., 365 
1988) and GT1 neurons (Krsmanovic et al., 1992). 366 
Prostaglandins were found to induces a membrane depolarization in native mouse GnRH neurons 367 
by the involvement of a non-selective cation current that require the cAMP/protein kinase A (PKA) 368 
pathway activation (Clasadonte et al., 2011; Coleman et al., 1994; Ojeda and Negro-Vilar, 1985; 369 
Roland and Moenter, 2011; Sang et al., 2005; Zhang et al., 2008). Accordingly, prostaglandin 370 
induces GnRH release in GT1 cells by promotion of cAMP formation and calcium mobilization 371 
(Ojeda and Negro-Vilar, 1985; Ojeda et al., 1985; Rage et al., 1997)  372 
Direct membrane depolarization induced by high extracellular concentration of K+ (from 7.5 to 60 373 
mM) also induces a dose-dependent increase of intracellular Ca2+ levels in GT1 neurons, with a 374 
consequent GnRH release, that involves voltage dependent N- and L-type Ca2+ channels (Javors et 375 
al., 1995; Krsmanovic et al., 1992; Stojilkovic et al., 1994). The action of K+ on GnRH release is not 376 
affected by a pretreatment with TTX excluding the involvement of sodium channels in such effect 377 
(Mellon et al., 1991). 378 
Collectively, several studies confirm that depolarization of the plasma membrane and influx of Ca2+ 379 
through L-type, and possibly N-type, calcium channels are associated functionally with the 380 
stimulated release of GnRH and may be shared by PGE1 and K
+ action. Therefore, the observation 381 
that nicotine inhibits the PGE1-induced GnRH release from GT1-1 cells without affecting the cAMP 382 
formation as well as blocks the release of GnRH promoted by exposure to high extracellular 383 
concentration of K+, lead to hypothesize that the activation of nAchRs might affect membrane 384 
depolarization. According to their pharmacological profile, the activation nAChRs may change ion 385 
permeability of the GT1-1 cell membrane, making the cells insensitive to external stimuli 386 
irrespective of the intracellular pathway activated. A postsynaptic inhibitory action of nAChRs in 387 
central neurons is supported by a study carried out on rat brain slices, in which the application of 388 
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nicotine was found to induce a marked neuronal hyperpolarization (Wong and Gallagher, 1989); 389 
however, the analysis of membrane ions currents under nicotine exposure by targeted 390 
electrophysiological experiments will help to clarify such hypothesis. 391 
It has been proposed that the inhibitory action of nicotine observed in vivo is not due to a direct 392 
effect of the cholinergic agonist on GnRH neurons.  The initial hypothesis suggesting the 393 
involvement of the opioid system (Pomerleau, 1998) was excluded by the observed insensitivity of 394 
nicotine effect to the opioid antagonist naloxone (Sano et al., 1999); more recently, it has been 395 
proposed that nicotine may stimulate the release of GABA which may inhibits GnRH release 396 
through GABA-A receptor (Kimura et al., 2004).  397 
It should be underlined that the results from experiments in organotypic cultures or in vivo may be 398 
altered by the interference of other neuronal inputs to GnRH neurons possibly activated or 399 
inhibited by modification of the cholinergic tone, possibly by pharmacological doses of nicotine 400 
that might not reflect the physiological role of the activation of nAChRs. 401 
GT1-1 cells may release GABA (Ahnert-Hilger et al., 1998) and the activation of GABA-A receptors 402 
induces an initial stimulatory action on GnRH release followed by an inhibitory phase possibly 403 
mediated by GABA-B receptors (Martinez de la Escalera et al., 1994). However, in contrast with 404 
the present results, in this case the inhibitory effect is mediated by a decrease of intracellular 405 
cAMP levels (Martin et al., 2007). 406 
Results from GT1-1 cells seem to confirm the hypothesis that the effects of nicotine on the 407 
reproductive system "in vivo" can be largely mediated by a direct inhibitory action on GnRH 408 
neurons, mediated by αBgtx-sensitive receptors (7 nAChR); this result does not exclude that 'in 409 
vivo' an additional indirect action of nicotine might be mediated by the activation of opioidergic or 410 
GABA interneurons. 411 
Our results apparently contrast with a previous study (Krsmanovic et al., 1998) suggesting that the 412 
activation of nicotinic receptors in perifused immortalized GnRH neurons causes a prompt 413 
transient increase in basal GnRH release followed by a return to basal levels.  414 
The discrepancy might be due to the different experimental procedures adopted in the two 415 
studies. Krsmanovic and coworkers (Krsmanovic et al., 1998) used immortalized GnRH neurons 416 
exposed to a lower concentration of nicotine (10 M), than in the present perifusion study (500 417 
M), and the effect of nicotine was not tested in conditions of stimulated GnRH release. 418 
Moreover, although the nAChR involved in the observed phenomena was not characterized, it is 419 
possible to speculate that exposure of the cells to low concentrations of nicotine might have 420 
induced a receptor desensitization-upregulation and biphasic response (as stated in the Results 421 
section) (Quick and Lester, 2002). 422 
The results of our study indicate that the GnRH release-inhibitory potency of nicotine (IC50 100-200 423 
M) is congruent with the potency found in activating channel current in neuronal cells (Arneric et 424 
al., 1994) and its affinity to rat brain 7 nAChR (Rueter et al., 2006). 425 
Evidence of a direct inhibitory effect of nicotine in central neurons, provided by studies in which 426 
nicotine application reduced Purkinje cells discharge (de la Garza et al., 1989) or induced 427 
membrane hyperpolarization mediated by an increase in potassium conductance (Wong and 428 
Gallagher, 1989), are consistent with the results of the current study. 429 
It is interesting to note that a greater number of nicotinic receptors are present in the brain of 430 
smokers (Benwell et al., 1988) since chronic nicotine induces a receptor upregulation with a partial 431 
receptor desensitization (Govind et al., 2009); this is true for α4/β2 nAChRs, the main high-affinity 432 
nicotine binding sites present in the brain; however, 7 nAChR were found not to be inactivated 433 
after up-regulation induced by chronic nicotine exposure (Kawai and Berg, 2001) making smokers 434 
more prone to the inhibitory effects of nicotine on GnRH release. 435 
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In conclusion, the results presented in this study demonstrate for the first time the presence of at 436 
least two classes of nAChRs on immortalized GnRH neurons (GT1-1 cell line) and that the 437 
activation of the αBgtx-sensitive subclass (possibly 7) produces an inhibitory effect on the release 438 
of GnRH.  439 
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Legends to figures 456 
 457 
Figure 1 Detection of nicotinic acetylcholine receptors in GT1-1 cells. 458 
Homologous saturation curves of the binding of (A)  3H-epibatidine (3H-Epi) and (B)   125I-a-459 
bungarotoxin (125I-Bgtx) on GT1-1 (circle) and HEK392 (triangle) cell membrane preparations 460 
Binding isotherms have been analyzed by LIGAND program. (C) RT-PCR amplified transcripts for 4, 461 
7 and 2 nicotine receptor subunits in GT1-1 cell total RNA. Normal adult mouse brain total RNA 462 
was used as internal control. Mouse Gapdh was used as housekeeping gene. 463 
 464 
Figure 2 Effect of the exposure to nicotine on the basal release of GnRH from GT1-1 cells.  465 
(A) Basal accumulation of immunoreactive GnRH in culture medium of GT1-1 cells after a 30 min 466 
static incubation in control (C) or in presence of increasing concentration of nicotine and 467 
cholinergic antagonists Bgtx (2.5 mM) and D-Tub (250 mM). Values are expressed as mean ± SEM 468 
(n=8). (B) Representative graphs (of four separate experiments) of perifused GT1-1 cells in absence 469 
and in presence of a 500 M concentration of nicotine; the segmented bar on top of the profile of 470 
GnRH release indicates the position and duration of secretory pulses identified by cluster analysis.  471 
 472 
Figure 3 Effect of the exposure to nicotine on the release of GnRH induced by PGE1 . 473 
(A) Representative dose response curve of the inhibitory action of nicotine on PGE1-induced GnRH 474 
release. The effect of nicotine is abolished in the presence of the antagonists (B) D-Tub and (C) 475 
Bgtx. Values are expressed as mean ± SEM (n=8); § p<0.05 vs basal release levels (B); * p<0.05 vs 476 
0. 477 
 478 
Figure 4  Nicotine does not modify the PGE1-induced cAMP accumulation in GT1-1 cells.   479 
The exposure of GT1-1 cells to nicotine or the antagonist D-Tub does not affect the intracellular 480 
accumulation of cAMP induced by PGE1. 481 
Values are expressed as mean ± SEM (n=8); § p<0.05 vs basal release levels (B). 482 
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 483 
Figure 5 Effect of the exposure to nicotine on the release of GnRH induced by 56 mM K+- . 484 
(A) Representative dose response curve of the inhibitory action of nicotine on 56 mM K+-induced 485 
GnRH release. The effect of nicotine is abolished in the presence of the antagonists (B) D-Tub and 486 
(C) Bgtx. Values are expressed as mean ± SEM (n=8); § p<0.05 vs basal release levels (B); * p<0.05 487 
vs 0. 488 
 489 
 490 
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Highlights  
 Immortalized GnRH neurons (GT1-1 ) express acetylcholine nicotinic receptors 
 Nicotine has not effect on basal accumulation of GnRH 
 Nicotine affects the pulsatility of GnRH release from GT1-1 cells 
 Nicotine exerts  an inhibitory action on stimulated GnRH release 
 The effect of nicotine does not affect intracellular cAMP levels 
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